L, M., X, L., JS, P., & SH, L. (2026). Development and Validation of a Multicyclic Peptide Targeting PD-L1 for Radiotheranostics. ACS medicinal chemistry letters, 17(3), 571. https://doi.org/10.1021/acsmedchemlett.5c00770
Chicago Style (17th ed.) CitationL, Meng, Li X, Patel JS, and Liang SH. "Development and Validation of a Multicyclic Peptide Targeting PD-L1 for Radiotheranostics." ACS Medicinal Chemistry Letters 17, no. 3 (2026): 571. https://doi.org/10.1021/acsmedchemlett.5c00770.
MLA (9th ed.) CitationL, Meng, et al. "Development and Validation of a Multicyclic Peptide Targeting PD-L1 for Radiotheranostics." ACS Medicinal Chemistry Letters, vol. 17, no. 3, 2026, p. 571, https://doi.org/10.1021/acsmedchemlett.5c00770.
Warning: These citations may not always be 100% accurate.